English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A sonochemistry-based method was used to synthesize a novel series of  N -cyclic imides substituted benzenesulfonamide using montmorillonite K10 as an efficient catalyst. Yields and reaction times needed for reaction completion using conventional heating, microwave (MW), and ultrasound (US) irradiation are compared. The environmentally friendly sonochemical method, in the presence of electron withdrawing and electron donating groups, afford the desired products in high yields and short time. The structures of the products were characterized by spectral data ( 1 H,  13 C NMR, and mass spectrometry). Molecular docking study was performed in order to evaluate synthesized compounds as possible inhibitors of human carbonic anhydrase I and II and their interactions in binding sites. Moreover, absorption, distribution, metabolism, and excretion properties were also assessed via Molinspiration software and all compounds obeyed Lipinski’s rule of five. In conclusion, the overall results of our study reveal that the synthesized compounds could be potential candidates in the search for novel carbonic anhydrases inhibitors.

phosphorus, sulfur, and silicon and the related elements

Ultrasound‐promoted green synthesis under montmorillonite K10 catalysis, characterization, ADME properties, and molecular docking study of a series of  N -cyclic imides substituted benzenesulfonamide as possible inhibitors of human carbonic anhydrase I and II